Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses

Current Protocols(2023)10.1002/cpz1.934Source: DataRank Database

The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses is a research paper published in Current Protocols (2023). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.37)OA: hybridTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Daniela Weiskopf ORCID,John Sidney ORCID,Paul Rubiro ORCID,Bjoern Peters ORCID,Cecilia S. Lindestam Arlehamn ORCID

Live enrichment

PubMed:37966108 PMC:PMC10662678 OpenAlex:https://openalex.org/W4388688552

NIAID NIH HHS

Grant: U19 AI142742

NIAID NIH HHS

Grant: 75N93019C00065

FWCI

4.37

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: other-oa

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpz1.934

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpz1.934

publisherhttps://currentprotocols.onlinelibrary.wiley.com/doi/pdf/10.1002/cpz1.934

journalhttps://doi.org/10.1002/cpz1.934

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37966108

Fields of Study

Immunotherapy and Immune Responsesvaccines and immunoinformatics approachesT-cell and B-cell ImmunologyHumansCD8-Positive T-LymphocytesEpitopes, T-LymphocyteEnzyme-Linked Immunospot AssayPeptidesCD4-Positive T-Lymphocytes

MeSH Terms

HumansPeptidesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEpitopes, T-LymphocyteEnzyme-Linked Immunospot Assay

Keywords

EpitopeELISPOTAntigenComputational biologyT cellMajor histocompatibility complexBiologyImmunologyCD8Epitope mappingImmune systemInfectious diseasesLyophilizationEpitopesAimSars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (2)

Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial

N/A

0.444DataRank · unranked

Open Forum Infectious Diseases(2024)

co-cited

10.1093/ofid/ofae689

Development of Influenza-Specific CD4 T Cell-Mediated Immunity in Children Following Inactivated Influenza Vaccination

Journal of the Pediatric Infectious Diseases Society(2024)

co-cited

10.1093/jpids/piae095